A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin
Neznamov GG, Teleshova ES · 2008 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
What does this source report?
Clinical publication located; results are not summarized because the indexed record provides no abstract.
- Population and setting
- Clinical population; enrollment and allocation not verified
- Evidence type
- Not classified
- Preparation
- See the original report; formulation details require verification.
- Source language
- See linked publication
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- No effect size, participant count or safety conclusion is inferred from the title.
- The 2008/2009 comparison and related EEG report may overlap; not counted as independent replication.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Indexed citation
Review depth: Metadata only
Related-report group: noopept-clinical-overlap-unresolved. Reports in this group are not assumed to be independent trials.
Source access and review scope
Indexed citation checked; complete article not recovered.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Neznamov GG, Teleshova ES. A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2008.
Molekul research summary: https://molekul.io/research/noopept-18697252. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Noopept
A defined synthetic dipeptide derivative connecting nootropic research with experimental environmental adaptation. Human chamber studies, clinical EEG reports and preclinical mechanisms address different questions; none establishes safe hazardous-work use.
Piracetam
Piracetam, marketed as Nootropil, connects the original nootropic concept with Soviet clinical adoption and later operator, hypoxia and maritime research. Healthy-volunteer experiments, clinical reviews and combination proposals answer different questions.